Cargando…
Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is considered related to chronic systemic inflammation. Renin angiotensin system (RAS) inhibitor, exerting an anti-inflammatory action in many systems, has been demonstrated relevant to the pathogenesis of COPD. However, the association betwee...
Autores principales: | Lv, Hongzhen, Huang, Jingyi, Miao, Miao, Huang, Cheng, Hang, Wenlu, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972452/ https://www.ncbi.nlm.nih.gov/pubmed/36828646 http://dx.doi.org/10.1136/bmjresp-2022-001569 |
Ejemplares similares
-
Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023) -
Longevity of pulmonary rehabilitation benefit for chronic obstructive pulmonary disease—health care utilisation in the subsequent 2 years
por: Walsh, James R, et al.
Publicado: (2019) -
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022) -
Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012) -
Vitamin D status and chronic obstructive pulmonary disease risk: a prospective UK Biobank study
por: Zhu, Zheng, et al.
Publicado: (2023)